GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1851 - 1875 of 4050 in total
Antibody Patient Onset (days) ▲ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 2 15 mild
G68703KI
4110
IgG Patient 2 15 mild
G69912LP
19530
IgG Patient 2 15 mild
G71142DF
103
IgG Patient 2 15 mild
G71469XA
263
IgG Patient 2 15 mild
G72424VO
74
IgG Patient 2 15 mild
G72739GY
705
IgG Patient 2 15 mild
G73271MD
72
IgG Patient 2 15 mild
G75896PD
158
IgG Patient 2 15 mild
G76355TG
207
IgG Patient 2 15 mild
G76615YG
30
IgG Patient 2 15 mild
G77974XY
99
IgG Patient 2 15 mild
G78074HX
44
IgG Patient 2 15 mild
G78255UI
511
IgG Patient 2 15 mild
G80587NA
794
IgG Patient 2 15 mild
G81315DD
107
IgG Patient 2 15 mild
G82096UQ
60
IgG Patient 2 15 mild
G82204SH
62
IgG Patient 2 15 mild
G82348BZ
31
IgG Patient 2 15 mild
G82779CI
44
IgG Patient 2 15 mild
G82942ZJ
27
IgG Patient 2 15 mild
G84224TW
73
IgG Patient 2 15 mild
G86156UJ
11027
IgG Patient 2 15 mild
G86541PE
311
IgG Patient 2 15 mild
G86566MF
36
IgG Patient 2 15 mild
G89993FE
38

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024